共 93 条
[1]
Vadivelu S(2015)Pediatric tone management Phys Med Rehabil Clin N Am 26 69-78
[2]
Stratton A(1998)Quality of life: effect of reduced spasticity from intrathecal baclofen J Neurosci Nurs 30 47-54
[3]
Pierce W(2010)Chemistry and pharmacology of GABA B receptor ligands Adv Pharmacol 58 1054-3589
[4]
Gianino JM(1989)Plasma and urinary excretion kinetics of oral baclofen in healthy subjects Eur J Clin Pharmacol 37 181-184
[5]
York MM(1999)A controlled pharmacokinetic evaluation of tizanidine and baclofen at steady state Drug Metab Dispos 27 201-204
[6]
Paice JA(2010)Assessment and treatment of movement disorders in children with cerebral palsy Orthop Clin North Am 41 507-517
[7]
Shott S(2014)Population pharmacokinetics of oral baclofen in pediatric patients with cerebral palsy The Journal of pediatrics 164 1181-8.e8
[8]
Froestl W(1977)A controlled trial of baclofen in children with cerebral palsy The Journal of international medical research 5 398-404
[9]
Wuis EW(2017)Pharmacogenomic variability of oral baclofen clearance and clinical response in children with cerebral palsy PM & R 10 235-243
[10]
Dirks MJ(2010)Practice parameter: pharmacologic treatment of spasticity in children and adolescents with cerebral palsy (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology and the Practice Committee of the Child Neurology Society Neurology 74 336-343